Pharmaceutical Executive-06-01-2010

Pharmaceutical Executive
Features

June 25, 2010

Strong, skilled management is on the agenda as never before. Find out who made 2010's roster of high-potential change masters-and how they plan to lead the industry through the turbulent times ahead.

Pharmaceutical Executive
Features

June 17, 2010

A new "upstream" healthcare model may help deliver on the longstanding promise of personalized medicine.

Issue PDF
Pharmaceutical Executive

June 01, 2010

Emerging Pharma Leaders

Back Page
Pharmaceutical Executive

June 01, 2010

The public-interest charity takes on pharma-influenced medicing and drug-resistant bacteria.

Pharmaceutical Executive

Social networking helps sponsors drive clinical trials recruitment.

Pharmaceutical Executive
Features

June 01, 2010

Lewis Morris, top lawyer in HHS's office of inspector general, explains his new move to target pharma execs for serious and ongoing healthcare fraud.

Pharmaceutical Executive

Improving communication means appealing to physicians' heads as well as their hearts.

Pharmaceutical Executive
Columns

June 01, 2010

Pharma companies can maximize partnership benefits with social media.

Pharmaceutical Executive
Washington Report

June 01, 2010

FDA and industry seek to ensure drug quality in a world complicated by global outsourcing and theft.

Pharmaceutical Executive

Innovation in industry has always required a strong internal champion; the danger is a process led by the risk-adverse and externally-driven stakeholder consensus called "death by faint praise." Is this really what we mean by "bold partnerships?"